# Mouse Core

> **NIH NIH P30** · COLUMBIA UNIVERSITY HEALTH SCIENCES · 2024 · $284,052

## Abstract

Rodent models of diabetes and its complications provide fundamental insights into the molecular basis of
human disease. The investigators of the Columbia Diabetes Research Center (DRC) employ more than one
hundred murine models to study the development, pathology and complications of diabetes and related
disorders. Modern tools to study diabetes in rodents and experimental manipulation of mice often requires
expensive equipment and technical skills that are beyond the means of individual investigators. The Mouse
Metabolic Function & Phenotyping Core (MMFPC) provides efficient, cost-effective, and timely services to DRC
investigators that enables researchers to carry out experiments that otherwise would be beyond their ability.
The MMFPC has been in great demand during the current funding cycle and has evolved significantly since the
last submission to meet the changing needs of DRC investigators. The MMFPC has proven broadly successful
in achieving its mission of assisting individual investigators in characterizing metabolic phenotypes of mice.
The MMFPC currently provides four broad services that facilitate the efficient characterization of mouse
models of diabetes and its complications: (i) Body Composition Analysis, (ii) Whole Body Metabolic
Assessment, (iii) Metabolic Clamps, and (iv) Metabolic Procedures & Surgeries. A service to isolate and
characterize extracellular vesicles is being implemented with a tentative start date of July 2022. The MMFPC
services complement those provided by other DRC Cores, so that investigators who take advantage of DRC
resources can fully characterize the histologic, immunologic, and metabolic function and phenotype of mice.
The Core has been built through the strong support of the Naomi Berrie Diabetes Center and Columbia
University. In response to investigator surveys and since our last competing renewal, we now provide a suite of
surgical procedures that will facilitate studies of the development and pathophysiology of diabetes. Projections
indicate that demand for Core services will remain high as we strengthen and grow our research base.

## Key facts

- **NIH application ID:** 10813091
- **Project number:** 5P30DK063608-22
- **Recipient organization:** COLUMBIA UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Anthony W Ferrante
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $284,052
- **Award type:** 5
- **Project period:** 2002-09-01 → 2027-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10813091

## Citation

> US National Institutes of Health, RePORTER application 10813091, Mouse Core (5P30DK063608-22). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10813091. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*